Found: 22
Select item for more details and to access through your institution.
The role of clonal progression leading to the development of therapy-related myeloid neoplasms.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3507, doi. 10.1007/s00277-024-05803-y
- By:
- Publication type:
- Article
Longitudinal detection of <italic>DNMT3A</italic><sup>R882H</sup> transcripts in patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. E120, doi. 10.1002/ajh.25061
- By:
- Publication type:
- Article
Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.064
- By:
- Publication type:
- Article
De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.030
- By:
- Publication type:
- Article
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.041
- By:
- Publication type:
- Article
Similarities and Differences Between Therapy-Related and Elderly Acute Myeloid Leukemia.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2011, v. 3, n. 1, p. 1, doi. 10.4084/MJHID.2011.052
- By:
- Publication type:
- Article
Characterization of FLT3-ITD<sup>mut</sup> acute myeloid leukemia: molecular profiling of leukemic precursor cells.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00352-9
- By:
- Publication type:
- Article
Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? – Response to Lucijanic and Kusec.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 4, p. 639, doi. 10.1111/bjh.15938
- By:
- Publication type:
- Article
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 4, p. e100, doi. 10.1111/bjh.15931
- By:
- Publication type:
- Article
Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 954, doi. 10.1111/bjh.15655
- By:
- Publication type:
- Article
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression.
- Published in:
- Biology (2079-7737), 2021, v. 10, n. 2, p. 128, doi. 10.3390/biology10020128
- By:
- Publication type:
- Article
Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes.
- Published in:
- Inflammation Research, 2023, v. 72, n. 8, p. 1695, doi. 10.1007/s00011-023-01773-5
- By:
- Publication type:
- Article
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-24644-1
- By:
- Publication type:
- Article
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.890344
- By:
- Publication type:
- Article
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.871590
- By:
- Publication type:
- Article
Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1373, doi. 10.3390/cancers11091373
- By:
- Publication type:
- Article
The Role of Forkhead Box Proteins in Acute Myeloid Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 865, doi. 10.3390/cancers11060865
- By:
- Publication type:
- Article
Therapy-related myeloid neoplasms: clinical perspectives.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 5909, doi. 10.2147/OTT.S101333
- By:
- Publication type:
- Article
Myelodysplastic disorders carrying both isolated del(5q) and JAK2<sup>V617F</sup> mutation: concise review, with focus on lenalidomide therapy.
- Published in:
- OncoTargets & Therapy, 2014, v. 7, p. 1043, doi. 10.2147/OTT.S59628
- By:
- Publication type:
- Article
Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 7, p. 2545, doi. 10.1007/s00277-024-05804-x
- By:
- Publication type:
- Article
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 11, p. 3015, doi. 10.1007/s00277-023-05384-2
- By:
- Publication type:
- Article
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia.
- Published in:
- Molecular & Clinical Oncology, 2018, v. 8, n. 3, p. 463, doi. 10.3892/mco.2017.1543
- By:
- Publication type:
- Article